Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial
- Resource Type
- Article
- Source
- In
Translational Oncology May 2024 43 - Subject
- Language
- ISSN
- 1936-5233